(347) Augmented Humoral Response to a Third And Fourth Dose of Mrna Sars-Cov-2 Vaccines in Lung Transplant Recipients

PURPOSE: Lung transplant recipients (LTRs) are at the greatest risk for mortality of COVID-19 among recipients of solid organ transplantation. However, LTRs have been shown to have impaired humoral response (0-40%) to the two doses of mRNA SARS-CoV-2 vaccine. In this study, we aimed to assess the hu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawana, S., Sugimoto, S., Matsubara, K., Tanaka, S., Miyoshi, K., Choshi, H., Ujike, H., Kubo, Y., Shimizu, D., Hashimoto, K., Shien, K., Suzawa, K., Yamamoto, H., Okazaki, M., Toyooka, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068044/
http://dx.doi.org/10.1016/j.healun.2023.02.1651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068044/
http://dx.doi.org/10.1016/j.healun.2023.02.1651

Ejemplares similares